The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Single-agent maintenance therapy for advanced-stage non-small cell lung cancer: A meta-analysis.
M. Behera
No relevant relationships to disclose
T. K. Owonikoko
No relevant relationships to disclose
Z. Chen
No relevant relationships to disclose
S. A. Kono
No relevant relationships to disclose
F. R. Khuri
No relevant relationships to disclose
C. P. Belani
Consultant or Advisory Role - Genentech; Lilly
S. S. Ramalingam
Consultant or Advisory Role - Astellas Pharma; Genentech; Lilly; OSI Pharmaceuticals